Caliway Biopharmaceuticals (6919.TW) Q1 2025 Earnings

Feb 7Confirmed
Q4 2024
Q1 2025
-1.36
-1.21
-1.06
-0.91

Details

Expected EPS
-1.2496760832499998
Actual EPS
-1.3595875941240039
Surprise EPS
-0.11
Surprise Percent
-8.8%

Description

⁨Caliway Biopharmaceuticals⁩ (⁦6919.TW⁩) has reported earnings of ⁦-1.3595875941240039⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts